VYJ: 11-cyclopentyl-2-({2-ethoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]phenyl}amino)-5-methyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one
VYJ is a Ligand Of Interest in 7LAZ designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 7LAZ_VYJ_B_201 | 76% | 10% | 0.115 | 0.951 | 1.9 | 2.47 | 9 | 25 | 0 | 0 | 100% | 1 |
| 7LAZ_VYJ_A_201 | 38% | 10% | 0.201 | 0.905 | 1.85 | 2.45 | 11 | 25 | 0 | 0 | 100% | 1 |
| 7K6G_VYJ_B_201 | 93% | 12% | 0.071 | 0.966 | 1.68 | 2.35 | 6 | 21 | 0 | 0 | 100% | 1 |
| 7L73_VYJ_A_201 | 74% | 13% | 0.103 | 0.934 | 1.83 | 2.17 | 10 | 19 | 0 | 0 | 100% | 1 |
| 7LEK_VYJ_B_401 | 51% | 1% | 0.196 | 0.952 | 5.36 | 3.58 | 28 | 19 | 1 | 0 | 100% | 1 |
| 7LAU_VYJ_A_201 | 33% | 6% | 0.204 | 0.881 | 1.85 | 3.22 | 9 | 30 | 0 | 0 | 100% | 1 |
| 7LBT_VYJ_B_501 | 31% | 8% | 0.219 | 0.89 | 2 | 2.6 | 12 | 26 | 0 | 0 | 100% | 1 |
